• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化学合成小干扰RNA及载体介导的RNA干扰方法。

Approaches for chemically synthesized siRNA and vector-mediated RNAi.

作者信息

Amarzguioui Mohammed, Rossi John J, Kim Dongho

机构信息

Division of Molecular Biology, Beckman Research Institute of the City of Hope, 1450 East Duarte Road, Duarte, CA 91010-3011, USA.

出版信息

FEBS Lett. 2005 Oct 31;579(26):5974-81. doi: 10.1016/j.febslet.2005.08.070. Epub 2005 Sep 20.

DOI:10.1016/j.febslet.2005.08.070
PMID:16199038
Abstract

Successful applications of RNAi in mammalian cells depend upon effective knockdown of targeted transcripts and efficient intracellular delivery of either preformed si/shRNAs or vector expressed si/shRNAs. We have previously demonstrated that 27 base pair double stranded RNAs which are substrates for Dicer can be up to 100 times more potent than 21mer siRNAs. In this mini-review we elaborate upon the rationale and design strategies for creating Dicer substrate RNAs that provide enhanced knockdown of targeted RNAs and minimize the utilization of the sense strand as RNAi effectors. Expression of shRNAs or siRNAs in mammalian cells can be achieved via transcription from either Pol II or Pol III promoters. There are certain constrictions in designing such vectors, and these are described here. Additionally, we review strategies for inducible shRNA expression and the various viral vectors that can be used to transduce shRNA genes into a variety of cells and tissues. The overall goal of this mini-review is to provide an overview of available approaches for optimizing RNAi mediated down regulation of gene expression in mammalian cells via RNA interference. Although the primary focus is the use of RNAi mediated cleavage of targeted transcripts, it is highly probable that some of the approaches described herein will be applicable to RNAi mediated inhibition of translation and transcriptional gene silencing.

摘要

RNA干扰(RNAi)在哺乳动物细胞中的成功应用取决于对靶向转录本的有效敲低以及对预先形成的小干扰RNA(siRNA)/短发夹RNA(shRNA)或载体表达的siRNA/shRNA的高效细胞内递送。我们之前已经证明,作为Dicer底物的27个碱基对的双链RNA比21个核苷酸的siRNA效力高100倍。在这篇小型综述中,我们详细阐述了创建Dicer底物RNA的基本原理和设计策略,这些RNA能增强对靶向RNA的敲低效果,并最大限度减少正义链作为RNAi效应物的利用。在哺乳动物细胞中,shRNA或siRNA的表达可通过RNA聚合酶II(Pol II)或RNA聚合酶III(Pol III)启动子转录来实现。设计此类载体存在一定限制,本文对此进行了描述。此外,我们还综述了诱导型shRNA表达的策略以及可用于将shRNA基因转导至多种细胞和组织的各种病毒载体。这篇小型综述的总体目标是概述通过RNA干扰优化RNAi介导的哺乳动物细胞基因表达下调的可用方法。虽然主要重点是利用RNAi介导的靶向转录本切割,但本文所述的一些方法很可能适用于RNAi介导的翻译抑制和转录基因沉默。

相似文献

1
Approaches for chemically synthesized siRNA and vector-mediated RNAi.化学合成小干扰RNA及载体介导的RNA干扰方法。
FEBS Lett. 2005 Oct 31;579(26):5974-81. doi: 10.1016/j.febslet.2005.08.070. Epub 2005 Sep 20.
2
Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.构建用于哺乳动物细胞中特定基因沉默的基于简单高效DNA载体的短发夹RNA表达系统。
Methods Mol Biol. 2007;408:223-41. doi: 10.1007/978-1-59745-547-3_13.
3
Characterisation and application of a bovine U6 promoter for expression of short hairpin RNAs.用于短发夹RNA表达的牛U6启动子的表征与应用
BMC Biotechnol. 2005 May 11;5:13. doi: 10.1186/1472-6750-5-13.
4
Expressing functional siRNAs in mammalian cells using convergent transcription.利用汇聚转录在哺乳动物细胞中表达功能性小干扰RNA。
BMC Biotechnol. 2003 Nov 6;3:21. doi: 10.1186/1472-6750-3-21.
5
Utility of Epstein-Barr virus-encoded small RNA promoters for driving the expression of fusion transcripts harboring short hairpin RNAs.爱泼斯坦-巴尔病毒编码的小RNA启动子用于驱动携带短发夹RNA的融合转录本表达的效用。
Gene Ther. 2008 Feb;15(3):191-202. doi: 10.1038/sj.gt.3303055. Epub 2007 Nov 1.
6
Overexpression of Dicer enhances RNAi-mediated gene silencing by short-hairpin RNAs (shRNAs) in human cells.在人类细胞中,Dicer的过表达增强了短发夹RNA(shRNA)介导的RNA干扰基因沉默作用。
Nucleic Acids Symp Ser (Oxf). 2004(48):191-2. doi: 10.1093/nass/48.1.191.
7
Gene silencing by small regulatory RNAs in mammalian cells.哺乳动物细胞中小调节性RNA介导的基因沉默
Cell Cycle. 2007 Feb 15;6(4):444-9. doi: 10.4161/cc.6.4.3807. Epub 2007 Feb 5.
8
Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors.使用慢病毒载体递送RNAi的短期细胞毒性作用和长期不稳定性。
BMC Mol Biol. 2004 Aug 3;5:9. doi: 10.1186/1471-2199-5-9.
9
Development of a species-specific RNA polymerase I-based shRNA expression vector.一种基于物种特异性RNA聚合酶I的短发夹RNA表达载体的开发。
Nucleic Acids Res. 2007;35(2):e10. doi: 10.1093/nar/gkl1045. Epub 2006 Dec 7.
10
Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys.通过共递送RNA诱饵减轻载体编码短发夹RNA的脱靶效应。
Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4007-16. doi: 10.1073/pnas.1510476112. Epub 2015 Jul 13.

引用本文的文献

1
Recent Update on siRNA Therapeutics.小干扰RNA疗法的最新进展
Int J Mol Sci. 2025 Apr 8;26(8):3456. doi: 10.3390/ijms26083456.
2
Identification of the RSX interactome in a marsupial shows functional coherence with the Xist interactome during X inactivation.鉴定有袋动物中的 RSX 相互作用组表明其与 X 染色体失活过程中的 Xist 相互作用组具有功能一致性。
Genome Biol. 2024 May 23;25(1):134. doi: 10.1186/s13059-024-03280-0.
3
A novel sustainable platform for scaled manufacturing of double-stranded RNA biopesticides.一种用于双链RNA生物农药规模化生产的新型可持续平台。
Bioresour Bioprocess. 2022 Oct 6;9(1):107. doi: 10.1186/s40643-022-00596-2.
4
A sporadic Parkinson's disease model via silencing of the ubiquitin-proteasome/E3 ligase component, SKP1A.通过沉默泛素-蛋白酶体/E3 连接酶组件 SKP1A 建立散发性帕金森病模型。
J Neural Transm (Vienna). 2024 Jun;131(6):675-707. doi: 10.1007/s00702-023-02687-6. Epub 2023 Aug 29.
5
Persistent detection of Tilapia lake virus in wild tilapia and tinfoil barbs.在野生罗非鱼和鲮鱼中持续检测到罗非鱼湖病毒。
Vet World. 2022 Apr;15(4):1097-1106. doi: 10.14202/vetworld.2022.1097-1106. Epub 2022 Apr 27.
6
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies.基于 RNAi 的治疗方法和新型 RNA 生物工程技术。
J Pharmacol Exp Ther. 2023 Jan;384(1):133-154. doi: 10.1124/jpet.122.001234. Epub 2022 Jun 9.
7
RNA Therapeutics - Research and Clinical Advancements.RNA疗法——研究与临床进展
Front Mol Biosci. 2021 Sep 22;8:710738. doi: 10.3389/fmolb.2021.710738. eCollection 2021.
8
Long Noncoding RNAs in Atherosclerosis and Vascular Injury: Pathobiology, Biomarkers, and Targets for Therapy.长链非编码 RNA 在动脉粥样硬化和血管损伤中的作用:病理生物学、生物标志物和治疗靶点。
Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2002-2017. doi: 10.1161/ATVBAHA.120.314222. Epub 2020 Jul 23.
9
Expanding the CRISPR Toolbox in Culicine Mosquitoes: Validation of Pol III Promoters.在库蚊中扩展 CRISPR 工具包:III 型聚合酶启动子的验证。
ACS Synth Biol. 2020 Mar 20;9(3):678-681. doi: 10.1021/acssynbio.9b00436. Epub 2020 Mar 4.
10
Insulin-like growth factor II mRNA binding protein 3 regulates proliferation, invasion and migration of neuroendocrine cancer cells.胰岛素样生长因子II mRNA结合蛋白3调节神经内分泌癌细胞的增殖、侵袭和迁移。
Int J Clin Exp Pathol. 2017 Oct 1;10(10):10269-10275. eCollection 2017.